Site-specific inhibition of neutrophilic inflammation by low-dose nanotherapy for immunoregulatory treatment of asthma
L Li, Y Ma, Y Hu, P Wang, S Han, X Zhang, J Zhang - Nano Today, 2023 - Elsevier
Asthma, one of the most common lung diseases, remains a serious global health problem.
Currently there is still an urgent need for effective and safe therapies against severe asthma …
Currently there is still an urgent need for effective and safe therapies against severe asthma …
Targeting type I PRMTs as promising targets for the treatment of pulmonary disorders: Asthma, COPD, lung cancer, PF, and PH
S Zhou, Q Zhang, H Yang, Y Zhu, X Hu, G Wan, L Yu - Life Sciences, 2024 - Elsevier
Pulmonary disorders, including asthma, chronic obstructive pulmonary disease (COPD),
pulmonary fibrosis (PF), pulmonary hypertension (PH), and lung cancer, seriously impair the …
pulmonary fibrosis (PF), pulmonary hypertension (PH), and lung cancer, seriously impair the …
[HTML][HTML] A review of the safety profile, antioxidant, anti-inflammatory, and bronchorelaxant activities of Waltheria indica Linn (Malvaceae): A potential antiasthmatic …
Z Yabré, R Boly, R Ouédraogo, AGV Coulidiaty… - Heliyon, 2024 - cell.com
Abstract Introduction Waltheria indica Linn (Malvaceae) is a widely distributed plant in West
Africa. It is commonly used in Burkina Faso to treat inflammation-related diseases, including …
Africa. It is commonly used in Burkina Faso to treat inflammation-related diseases, including …
Protein Coronas Derived from Mucus Act as Both Spear and Shield to Regulate Transferrin Functionalized Nanoparticle Transcellular Transport in Enterocytes
D Yang, Y Feng, Y Yuan, L Zhang, Y Zhou… - ACS …, 2024 - ACS Publications
The epithelial mucosa is a key biological barrier faced by gastrointestinal, intraoral,
intranasal, ocular, and vaginal drug delivery. Ligand-modified nanoparticles demonstrate …
intranasal, ocular, and vaginal drug delivery. Ligand-modified nanoparticles demonstrate …
[HTML][HTML] On the path to predicting immune responses in the lung: Modeling the pulmonary innate immune system at the air-liquid interface (ALI)
Chronic respiratory diseases and infections are among the largest contributors to death
globally, many of which still have no cure, including chronic obstructive pulmonary disorder …
globally, many of which still have no cure, including chronic obstructive pulmonary disorder …
[HTML][HTML] A bio-adhesion nanogel particle as an anti-inflammation agent for efficient aerosol inhalation therapy to asthma
YB Chen, JY Hou, XY Yue, Y Wang, J Huang, D Xu… - Materials & Design, 2024 - Elsevier
Asthma is a heterogeneous respiratory disease characterized by airway inflammation
occurring in the bronchus. Direct delivery of targeted treatments to the bronchus for asthma …
occurring in the bronchus. Direct delivery of targeted treatments to the bronchus for asthma …